samedan logo
 
 
spacer
home > ebr > spring 2003 > the biosaxony region
PUBLICATIONS
European Biopharmaceutical Review

The biosaxony Region

"There's one thing I am certain of... Saxony will soon be Germany's main biotechnology centre..." - Professor Guenter Blobel (Nobel Prize for Medicine, 1999)

Should every nation, state, city, town and village develop their own biotechnology cluster? What is biosaxony and how could it possibly be different from the many other bio-locations? As you read this article, hopefully you will agree that there are unique elements to biosaxony that justify taking a closer look. First there are the people; the ready availability of a highly trained and motivated workforce with (together with Portugal) the lowest labour rates in Europe. Rates will stay low as Eastern Europe opens up in 2004 and the availability of skilled labour is further supplemented.

Next there is the infrastructure - the most modern in Europe with 100 per cent digital communication systems and fibre-optic networks, gas, electricity and waste disposal functionality at green field locations, as well as modern roads, airports and rail networks which have all been rebuilt within the last 10 years.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Ivan Baines, Partner at Biopolis Consultants

Dr Baines received his PhD in Cell Biology and Biochemistry from University College London in 1988 and performed postdoctoral and independent research at the National Institutes of Health (USA). He then joined the National Heart, Lung and Blood Institute (NHLBI) to help administer its $2.8 billion budget for basic and clinical life sciences research.

While promoting the NHLBI's Small Business Innovation Research (SBIR) award programme, Dr Baines advised over 100 new start-ups within life sciences. He also helped turn the revenue balance of the NHLBI's patent portfolio from loss to profit in under two years. Dr Baines helped to set up and run the Max Planck Institute for Molecular Cell Biology and Genetics in Dresden as Scientific Co-ordinator and Director of Services and Facilities, before co-founding Biopolis Consultants in 2001.

spacer
Dr Ivan Baines
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

BioPartnering Latin America™ (BPL)

19-21 September 2010, Rio de Janeiro

BioPartnering Latin America™ (BPL) will bring together professionals from all over the world, including the Latin American region from Mexico to Chile, Brazil, and Argentina. The focus of BPL will be life science, including human, animal and plant health and technology; highlighting the fast growing sector of innovative Latin American companies which will present significant partnering opportunities. BPL will offer three days of networking opportunities filled with pre-scheduled face-to-face partnering meetings, expert panels and workshops. BPL is presenting the opportunity to explore the emerging market of Latin America. Register for BPL and connect your company with The Global Life Science Network™. For more information and to register, please visit: http://www.techvision.com/bpl/
More info >>

 
News and Press Releases

PharmaBrand Summit 2010

Top pharmaceutical executives shared best practices at the PharmaBrand Summit 2010, which took place on the 21st to 23rd June 2010 in Monte-Carlo, Monaco and was organised by Marcus Evans
More info >>

 

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement